Tofacitinib citrate and Soluprep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tofacitinib citrate (tofacitinib citrate) and Soluprep (2%chlorhexidine gluconate;70% isopropyl alcohol). Common drug interactions include irritable bowel syndrome among females.

The phase IV clinical study analyzes what interactions people have when they take Tofacitinib citrate and Soluprep. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Tofacitinib citrate?

Tofacitinib citrate has active ingredients of tofacitinib citrate. eHealthMe is studying from 7,767 Tofacitinib citrate users. Check the latest studies of Tofacitinib citrate.

What is Soluprep?

Soluprep has active ingredients of 2%chlorhexidine gluconate;70% isopropyl alcohol. eHealthMe is studying from 40 Soluprep users. Check the latest studies of Soluprep.

On Jul, 26, 2026

14 people who take Tofacitinib citrate and Soluprep together, and have interactions are studied.

Tofacitinib citrate and Soluprep drug interactions.

What are the common drug interactions of Tofacitinib Citrate and Soluprep, by gender? *:

female:

Irritable bowel syndrome
Abdominal pain upper
Infusion related reaction
Joint swelling
Maternal exposure during pregnancy (use of substance during pregnancy)
Muscle injury
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters)
Weight increased
Abdominal discomfort
Alopecia (absence of hair from areas of the body)

male:

n/a

What are the common drug interactions of Tofacitinib Citrate and Soluprep, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anti-cyclic citrullinated peptide antibody positive
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Maternal exposure during pregnancy (use of substance during pregnancy)
Muscle injury
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters)
Weight increased
Abdominal discomfort
Alopecia (absence of hair from areas of the body)
Discomfort
Drug ineffective

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 13 people, 92.86%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 64.29%
Stress And Anxiety: 8 people, 57.14%
Psoriasis (immune-mediated disease that affects the skin): 6 people, 42.86%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 4 people, 28.57%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 28.57%
Fever: 4 people, 28.57%
Inflammation: 3 people, 21.43%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 21.43%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Tofacitinib citrate and Soluprep?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously